AAN.com
Quick search in Citations
AnywhereCitation
Advanced Search
Trending Terms:
BRIEF COMMUNICATION
October 1, 1995

Anticonvulsant effect of fluoxetine in humans

E. Favale, MD, V. Rubino, MD, P. Mainardi, PhD, G. Lunardi, PhD, and C. Albano, MDAuthors Info & Affiliations
October 1995 issue
45 (10) 1926-1927
https://doi.org/10.1212/WNL.45.10.1926
Letters to the Editor
Track CitationsAdd to favorites
Get Access

Abstract

We report an unblinded, open-label, add-on trial of fluoxetine, a selective serotonin reuptake inhibitor, in 17 patients with complex partial seizures with and without secondary generalization (mean follow-up duration, 14 plus minus 1.1 months). Six patients showed complete disappearance of their daily seizures; in the others the seizure frequency was lowered by 30%. No patient reported side effects.
NEUROLOGY 1995;45: 1926-1927

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

REFERENCES

1.
Scudder CL, Karczmar AG, Everett GM, Gibson JE, Rifkin M. Brain catecholamines and serotonin values in various strains and genera of mice and a possible interpretation for the correlation of amine levels with electroshock latency and behaviour. Int J Neuropharmacol 1966;5:343-351.
Google Scholar
2.
Trimble M, Anlezark G, Meldrum M. Seizure activity in photosensitive baboons following antidepressant drugs and the role of the serotoninergic mechanisms. Psychopharmacology (Berlin) 1977;51:159-164.
Google Scholar
3.
Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide. Epilepsia 1992;33:573-576.
Google Scholar
4.
Pasini A, Tortorella A, Gale K. Anticonvulsant effect of intranigral fluoxetine. Brain Res 1992;593:287-290.
Google Scholar
5.
Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC. Effects of fluoxetine on convulsion and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992;260:533-540.
Google Scholar
6.
Prendeville S, Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures. Epilepsia 1993;34:381-384.
Google Scholar
7.
Spina E, Avenoso A, Pollicino AM, Fazio A, Pisani F, Caputi AP. No effect of fluvoxamine and fluoxetine on plasma concentrations of carbamazepine in epileptic patients. Pharmacol Res 1992;(suppl 2):214-215.
Google Scholar
8.
Weber JJ. Seizure activity associated with fluoxetine therapy. Clin Pharm 1989;8:296-298.
Google Scholar
9.
Ware MR, Stewart RB. Seizures associated with fluoxetine therapy [abstract]. Ann Pharmacother 1989;23:428.
Google Scholar
10.
Tata MR, Lettieri B, Vicario C. Osservazioni su di un caso di inaspettato stato di male convulsivo: ruolo della fluoxetina [abstract]. Boll Lega It Epil 1993;84:167.
Google Scholar

Information & Authors

Information

Published In

Neurology®
Volume 45 • Number 10 • October 1995
Pages: 1926-1927
PubMed: 7477995

Copyright

Copyright 1995 by Advanstar Communications Inc.

Publication History

Published online: October 1, 1995
Published in print: October 1995

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

From the Institute of Clinical Neurology, Genoa University, Genoa, Italy.
Supported in part by C.N.R. Cerebral Neurophysiology of Genoa.
Received September 13, 1994. Accepted in final form March 2, 1995.
Address correspondence and reprint requests to Dr. Claudio Albano, Clinica Neurologica dell'Universita', Via A. De Toni, 5, 16132 Genova, Italy.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
    • H. Florence Kim,
    • Frank Y. Chen,
    • Stuart C. Yudofsky,
    • Robert E. Hales,
    • Gary J. Tucker,
    • Robert E. Hales,
    Chapter 5. Seizure Disorders, Clinical Manual of Neuropsychiatry, (181-210), (2024).https://doi.org/10.1176/appi.books.9781615378302.lg05
    Crossref
    • Donald P. Rogers,
    Chapter 2. Antidepressants, Handbook of Essential Psychopharmacology, Second Edition, (19-138), (2024).https://doi.org/10.1176/appi.books.9781615377398.lg02
    Crossref
    • Paige A Whyte-Fagundes,
    • Anjelica Vance,
    • Aloe Carroll,
    • Francisco Figueroa,
    • Catherine Manukyan,
    • Scott C Baraban,
    Testing of putative antiseizure medications in a preclinical Dravet syndrome zebrafish model, Brain Communications, 6, 3, (2024).https://doi.org/10.1093/braincomms/fcae135
    Crossref
    • Hrvoje Hećimović,
    “Mood, psychosis and suicidal behavior in epilepsy”, Seizure: European Journal of Epilepsy, (2024).https://doi.org/10.1016/j.seizure.2024.09.007
    Crossref
    • Martina Tallarico,
    • Maria Pisano,
    • Antonio Leo,
    • Emilio Russo,
    • Rita Citraro,
    • Giovambattista De Sarro,
    Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand?, Current Neuropharmacology, 21, 8, (1691-1713), (2023).https://doi.org/10.2174/1570159X20666220627160048
    Crossref
    • Kelsey K. Wiggs,
    • Tyra Lagerberg,
    • Patrick D. Quinn,
    • A. Sara Öberg,
    • Henrik Larsson,
    • Zheng Chang,
    • Brian M. D’Onofrio,
    A nationwide study of initiation of antidepressant pharmacotherapy and the risk of seizures, Epilepsy Research, 192, (107134), (2023).https://doi.org/10.1016/j.eplepsyres.2023.107134
    Crossref
    • Alexandre Magno da Nobrega Marinho,
    • Bruno Lobão-Soares,
    • Hugo Alexandre Sousa Targino,
    • Yago José Fernandes Vasconcellos,
    • Ricardo Guarnieri,
    • Carlos Gilberto Carlotti,
    Decreased hippocampal serotonin 5HT1A expression in mesial temporal lobe of epilepsy patients, Epilepsy & Behavior, 129, (108574), (2022).https://doi.org/10.1016/j.yebeh.2022.108574
    Crossref
    • Parthena Martin,
    • Tangui Maurice,
    • Arnold Gammaitoni,
    • Gail Farfel,
    • Brooks Boyd,
    • Bradley Galer,
    Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo, Epilepsy & Behavior, 127, (108526), (2022).https://doi.org/10.1016/j.yebeh.2021.108526
    Crossref
    • Frida A. Teran,
    • Eduardo Bravo,
    • George B. Richerson,
    Sudden unexpected death in epilepsy: Respiratory mechanisms, Respiratory Neurobiology: Physiology and Clinical Disorders, Part II, (153-176), (2022).https://doi.org/10.1016/B978-0-323-91532-8.00012-4
    Crossref
    • Maria Antonia Serra-Pinheiro,
    • Isabella D'andrea-Meira,
    • Abraão Iuri Medeiros Angelim,
    • Fernanda Alves Fonseca,
    • Nicolle Zimmermann,
    High prevalence of psychiatric comorbidities in children and adolescents at a tertiary epilepsy center, Arquivos de Neuro-Psiquiatria, 79, 6, (521-526), (2021).https://doi.org/10.1590/0004-282x-anp-2020-0202
    Crossref
  11. See more

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share

View full text|Download PDF